Skeletal Effects of the Saturated 3-Thia Fatty Acid Tetradecylthioacetic Acid in Rats

Author:

Stunes Astrid Kamilla1,Westbroek Irene2,Fossmark Reidar13,Berge Rolf Kristian45,Reseland Janne Elin6,Syversen Unni17

Affiliation:

1. Department of Cancer Research and Molecular Medicine, Faculty of Medicine, MTFS, Norwegian University of Science and Technology, NTNU, Olav Kyrres gate 9, 7489 Trondheim, Norway

2. Departments of Orthopedics and Internal Medicine, Erasmus University, 3000 DR, Rotterdam, The Netherlands

3. Department of Gastroenterology and Hepatology, St. Olav's University Hospital, 7006 Trondheim, Norway

4. Department of Medicine, University of Bergen, 5020 Bergen, Norway

5. Department of Heart Diseases, Haukeland University Hospital, 5021 Bergen, Norway

6. Department of Biomaterials, Institute for Clinical Dentistry, University of Oslo, 0317 Oslo, Norway

7. Department of Endocrinology, St. Olav's University Hospital, 7030 Trondheim, Norway

Abstract

This study explores the skeletal effects of the peroxisome proliferator activated receptor (PPAR)pan agonist tetradecylthioacetic acid (TTA). Rats, without (Study I) and with ovariectomy (OVX) or sham operation (Study II), were given TTA or vehicle daily for 4 months. Bone markers in plasma, whole body and femoral bone mineral density and content (BMD and BMC), and body composition were examined. Histomorphometric and biomechanical analyses (Study I) and biomechanical and μCT analyses (Study II) of the femur were performed. Normal rats fed TTA had higher femoral BMD and increased total and cortical area in femur compared to controls. The ovariectomized groups had decreased BMD and impaired microarchitecture parameters compared to SHAM. However, the TTA OVX group maintained femoral BMC, trabecular thickness in the femoral head, and cortical volume in the femoral metaphysis as SHAM. TTA might increase BMD and exert a light preventive effect on estrogen-related bone loss in rats.

Funder

Nycomed Pharma

Publisher

Hindawi Limited

Subject

Pharmacology (medical),Drug Discovery

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3